These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 9335072)

  • 1. The efficacy of monopyridinium (2-PAAM, 2-PAEM) and bispyridinium (obidoxime, HI-6) oximes against mevinphos in mice.
    Kassa J; Bielavský J
    Pharmacol Toxicol; 1997 Sep; 81(3):144-6. PubMed ID: 9335072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of the efficacy of new monopyridinium oximes with the oxime HI-6 against mevinphos in mice.
    Kassa J; Bielavský J
    Acta Medica (Hradec Kralove); 1999; 42(1):9-11. PubMed ID: 10566173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparison of the effects of BI-6, a new asymmetric bipyridine oxime, with HI-6 oxime and obidoxime in combination with atropine on soman and fosdrine toxicity in mice].
    Kassa J
    Ceska Slov Farm; 1999 Jan; 48(1):44-7. PubMed ID: 10376416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Some benefit from non-oximes MB408, MB442 and MB444 in combination with the oximes HI-6 or obidoxime and atropine in antidoting sarin or cyclosarin poisoned mice.
    Kassa J; Timperley CM; Bird M; Williams RL; Green AC; Tattersall JEH
    Toxicology; 2018 Sep; 408():95-100. PubMed ID: 30005893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of the potency of newly developed oximes (K074, K075) and currently available oximes (obidoxime, trimedoxime, HI-6) to counteract acute toxic effects of tabun and cyclosarin in mice.
    Kassa J; Humlicek V
    Drug Chem Toxicol; 2008; 31(1):127-35. PubMed ID: 18161512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of the reactivating and therapeutic efficacy of two novel bispyridinium oximes (K727, K733) with the oxime HI-6 and obidoxime in sarin-poisoned rats and mice.
    Kassa J; Sepsova V; Matouskova L; Horova A; Musilek K
    Toxicol Mech Methods; 2015 Mar; 25(3):229-33. PubMed ID: 25894563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An evaluation of therapeutic and reactivating effects of newly developed oximes (K156, K203) and commonly used oximes (obidoxime, trimedoxime, HI-6) in tabun-poisoned rats and mice.
    Kassa J; Karasova J; Musilek K; Kuca K
    Toxicology; 2008 Jan; 243(3):311-6. PubMed ID: 18054821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparison of the therapeutic effectiveness of selected cholinesterase reactivators with atropine in acute fosdrine poisoning in mice].
    Kassa J; Bajgar J
    Ceska Slov Farm; 1996 Feb; 45(1):31-4. PubMed ID: 8620316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of the reactivating and therapeutic efficacy of newly developed oximes (K347, K628) with commonly used oximes (obidoxime, HI-6) against tabun in rats and mice.
    Kassa J; Karasova JZ; Kuca K; Musilek K
    Drug Chem Toxicol; 2010 Jul; 33(3):227-32. PubMed ID: 20429807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of the potency of newly developed oximes (K027, K048) and commonly used oximes (obidoxime, HI-6) to counteract tabun-induced neurotoxicity in rats.
    Kassa J; Kunesova G
    J Appl Toxicol; 2006; 26(4):309-16. PubMed ID: 16552727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the neuroprotective efficacy of newly developed oximes (K206, K269) and currently available oximes (obidoxime, HI-6) in cyclosarin-poisoned rats.
    Kassa J; Karasova JZ; Bajgar J; Tesarova S; Kuca K; Musilek K
    Basic Clin Pharmacol Toxicol; 2009 Mar; 104(3):228-35. PubMed ID: 19143747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bispyridinium oximes as antidotal treatment of cyclosarin poisoning-in vitro and in vivo testing.
    Bartosova L; Kuca K; Jun D; Kunesova G
    Int J Toxicol; 2005; 24(6):399-402. PubMed ID: 16393932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of tabun-inhibited rat brain acetylcholinesterase reactivation by three oximes (HI-6, obidoxime, and K048) in vivo detected by biochemical and histochemical techniques.
    Bajgar J; Hajek P; Zdarova JK; Kassa J; Paseka A; Slizova D; Krs O; Kuca K; Jun D; Fusek J; Capek L
    J Enzyme Inhib Med Chem; 2010 Dec; 25(6):790-7. PubMed ID: 21054236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of the potency of a novel bispyridinium oxime K203 and currently available oximes (obidoxime, HI-6) to counteract the acute neurotoxicity of sarin in rats.
    Kassa J; Misik J; Karasova JZ
    Basic Clin Pharmacol Toxicol; 2012 Nov; 111(5):333-8. PubMed ID: 22536919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An evaluation of reactivating and therapeutic efficacy of newly developed oximes (K206, K269) and commonly used oximes (obidoxime, HI-6) in cyclosarin-poisoned rats and mice.
    Kassa J; Karasova J; Musilek K; Kuca K; Bajgar J
    Clin Toxicol (Phila); 2009 Jan; 47(1):72-6. PubMed ID: 18686075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroprotective effects of currently used antidotes in tabun-poisoned rats.
    Kassa J; Krejèová G
    Pharmacol Toxicol; 2003 Jun; 92(6):258-64. PubMed ID: 12787257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the efficacy of HI-6 and obidoxime against cyclohexyl methylphosphonofluoridate (GF) in rats.
    Kassa J; Bajgar J
    Hum Exp Toxicol; 1995 Nov; 14(11):923-8. PubMed ID: 8588955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toxicity and median effective doses of oxime therapies against percutaneous organophosphorus pesticide and nerve agent challenges in the Hartley guinea pig.
    Snider TH; Babin MC; Jett DA; Platoff GE; Yeung DT
    J Toxicol Sci; 2016; 41(4):511-21. PubMed ID: 27432237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of reactivating efficacy of newly developed oximes (K074, K075) and currently available oximes (obidoxime, HI-6) in cyclosarin-and tabun-poisoned rats.
    Kassa J; Jun D; Kuca K
    J Enzyme Inhib Med Chem; 2007 Jun; 22(3):297-300. PubMed ID: 17674811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reactivation of nerve agent-inhibited human acetylcholinesterase by obidoxime, HI-6 and obidoxime+HI-6: Kinetic in vitro study with simulated nerve agent toxicokinetics and oxime pharmacokinetics.
    Worek F; Koller M; Thiermann H; Wille T
    Toxicology; 2016 Mar; 350-352():25-30. PubMed ID: 27153754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.